 Beth Tamburini
Concepts (228)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B7-H1 Antigen | 6 | 2022 | 142 | 2.910 |
Why?
| | Endothelial Cells | 10 | 2022 | 681 | 2.640 |
Why?
| | Lymph Nodes | 7 | 2021 | 423 | 2.510 |
Why?
| | Antigens | 4 | 2022 | 318 | 2.340 |
Why?
| | Dendritic Cells | 7 | 2021 | 436 | 1.910 |
Why?
| | Lymphatic Vessels | 6 | 2019 | 54 | 1.770 |
Why?
| | Antigen Presentation | 4 | 2021 | 189 | 1.340 |
Why?
| | Programmed Cell Death 1 Receptor | 2 | 2021 | 195 | 1.240 |
Why?
| | Endothelium, Lymphatic | 2 | 2018 | 12 | 1.130 |
Why?
| | CD8-Positive T-Lymphocytes | 5 | 2020 | 689 | 0.970 |
Why?
| | Single-Cell Analysis | 3 | 2021 | 188 | 0.850 |
Why?
| | Paxillin | 1 | 2022 | 10 | 0.840 |
Why?
| | Saccharomyces cerevisiae | 5 | 2012 | 477 | 0.800 |
Why?
| | Liver | 3 | 2020 | 1631 | 0.780 |
Why?
| | Dermis | 1 | 2020 | 30 | 0.720 |
Why?
| | Hemangiosarcoma | 2 | 2010 | 18 | 0.690 |
Why?
| | Immunity | 1 | 2020 | 121 | 0.680 |
Why?
| | Cell Movement | 3 | 2020 | 867 | 0.670 |
Why?
| | Interferon Type I | 2 | 2018 | 128 | 0.670 |
Why?
| | Mice, Inbred C57BL | 13 | 2021 | 4710 | 0.640 |
Why?
| | Vaccines | 2 | 2022 | 375 | 0.640 |
Why?
| | Saccharomyces cerevisiae Proteins | 4 | 2008 | 333 | 0.630 |
Why?
| | Histones | 4 | 2008 | 536 | 0.600 |
Why?
| | Immunity, Cellular | 2 | 2019 | 248 | 0.590 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1134 | 0.580 |
Why?
| | Cell Proliferation | 4 | 2019 | 2196 | 0.560 |
Why?
| | Hepatitis C, Chronic | 1 | 2019 | 151 | 0.560 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2019 | 245 | 0.520 |
Why?
| | Animals | 22 | 2022 | 31762 | 0.520 |
Why?
| | Mice | 15 | 2022 | 14916 | 0.500 |
Why?
| | T-Lymphocytes | 4 | 2015 | 1745 | 0.500 |
Why?
| | Flow Cytometry | 1 | 2019 | 1086 | 0.490 |
Why?
| | Molecular Chaperones | 3 | 2008 | 157 | 0.490 |
Why?
| | Cell Differentiation | 3 | 2019 | 1699 | 0.470 |
Why?
| | Immunotherapy | 2 | 2021 | 475 | 0.440 |
Why?
| | Gene Expression Profiling | 2 | 2010 | 1521 | 0.440 |
Why?
| | Antigens, Viral | 1 | 2014 | 176 | 0.440 |
Why?
| | Viral Vaccines | 1 | 2014 | 88 | 0.430 |
Why?
| | Cell Cycle Proteins | 3 | 2008 | 552 | 0.410 |
Why?
| | Virus Diseases | 1 | 2014 | 195 | 0.400 |
Why?
| | Dogs | 2 | 2010 | 334 | 0.390 |
Why?
| | Breast Neoplasms | 2 | 2019 | 1868 | 0.370 |
Why?
| | Lymphocyte Activation | 5 | 2021 | 1044 | 0.360 |
Why?
| | Poly I-C | 2 | 2020 | 51 | 0.340 |
Why?
| | Mice, Knockout | 6 | 2021 | 2582 | 0.330 |
Why?
| | Silent Information Regulator Proteins, Saccharomyces cerevisiae | 2 | 2006 | 7 | 0.330 |
Why?
| | Breeding | 1 | 2009 | 55 | 0.330 |
Why?
| | Dog Diseases | 1 | 2009 | 41 | 0.320 |
Why?
| | Neovascularization, Pathologic | 1 | 2010 | 283 | 0.320 |
Why?
| | Biomarkers | 1 | 2019 | 3416 | 0.320 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2010 | 1147 | 0.300 |
Why?
| | Gene Silencing | 2 | 2006 | 172 | 0.300 |
Why?
| | Interleukin-6 | 1 | 2012 | 675 | 0.300 |
Why?
| | Sequence Analysis, RNA | 2 | 2021 | 388 | 0.300 |
Why?
| | Signal Transduction | 1 | 2020 | 4522 | 0.290 |
Why?
| | DNA Repair | 2 | 2008 | 186 | 0.290 |
Why?
| | DNA | 2 | 2021 | 1351 | 0.270 |
Why?
| | Antigens, CD | 2 | 2019 | 443 | 0.270 |
Why?
| | Mice, Transgenic | 4 | 2021 | 1951 | 0.270 |
Why?
| | Ribonucleases | 1 | 2006 | 52 | 0.260 |
Why?
| | Mutation | 4 | 2022 | 3350 | 0.260 |
Why?
| | Lymphoid Tissue | 2 | 2022 | 62 | 0.240 |
Why?
| | Cell Line, Tumor | 4 | 2021 | 2725 | 0.240 |
Why?
| | Recombination, Genetic | 1 | 2005 | 176 | 0.230 |
Why?
| | Chemokine CCL21 | 2 | 2020 | 13 | 0.220 |
Why?
| | Ovalbumin | 2 | 2021 | 161 | 0.220 |
Why?
| | Macrophages | 2 | 2021 | 1261 | 0.210 |
Why?
| | Repressor Proteins | 3 | 2021 | 367 | 0.210 |
Why?
| | Mice, Inbred BALB C | 3 | 2021 | 1151 | 0.210 |
Why?
| | Tumor Microenvironment | 3 | 2021 | 433 | 0.200 |
Why?
| | Receptors, Pattern Recognition | 1 | 2022 | 9 | 0.200 |
Why?
| | Vaccinia virus | 1 | 2022 | 28 | 0.200 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 2 | 2019 | 54 | 0.200 |
Why?
| | Inflammation | 3 | 2019 | 2481 | 0.200 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 2 | 2021 | 39 | 0.190 |
Why?
| | Chikungunya Fever | 2 | 2021 | 61 | 0.190 |
Why?
| | Phosphorothioate Oligonucleotides | 1 | 2021 | 9 | 0.190 |
Why?
| | Caveolae | 1 | 2021 | 15 | 0.190 |
Why?
| | Alphavirus Infections | 1 | 2021 | 41 | 0.190 |
Why?
| | Janus Kinase 1 | 1 | 2020 | 23 | 0.180 |
Why?
| | Receptors, CCR7 | 1 | 2020 | 24 | 0.180 |
Why?
| | Janus Kinase 2 | 1 | 2020 | 31 | 0.180 |
Why?
| | Viremia | 1 | 2021 | 123 | 0.180 |
Why?
| | Receptors, CCR2 | 1 | 2020 | 28 | 0.180 |
Why?
| | Immune System | 1 | 2022 | 173 | 0.180 |
Why?
| | Azetidines | 1 | 2020 | 31 | 0.180 |
Why?
| | Tissue Distribution | 1 | 2021 | 285 | 0.180 |
Why?
| | Receptors, Immunologic | 1 | 2021 | 201 | 0.180 |
Why?
| | Protein Kinase Inhibitors | 2 | 2020 | 795 | 0.180 |
Why?
| | Radiation Tolerance | 1 | 2021 | 92 | 0.180 |
Why?
| | Endocytosis | 1 | 2021 | 149 | 0.180 |
Why?
| | Membrane Glycoproteins | 2 | 2019 | 429 | 0.170 |
Why?
| | GTP-Binding Proteins | 1 | 2020 | 139 | 0.170 |
Why?
| | Chemotaxis | 1 | 2020 | 130 | 0.170 |
Why?
| | Polymerization | 1 | 2020 | 119 | 0.170 |
Why?
| | Cell Count | 1 | 2020 | 305 | 0.170 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2020 | 157 | 0.170 |
Why?
| | Postpartum Period | 2 | 2019 | 281 | 0.170 |
Why?
| | Exons | 1 | 2020 | 303 | 0.170 |
Why?
| | Cells, Cultured | 2 | 2021 | 3890 | 0.170 |
Why?
| | Protein Domains | 1 | 2020 | 207 | 0.170 |
Why?
| | Platelet Factor 4 | 1 | 2019 | 21 | 0.160 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2021 | 152 | 0.160 |
Why?
| | Mammary Neoplasms, Experimental | 1 | 2019 | 64 | 0.160 |
Why?
| | Receptors, Interferon | 1 | 2019 | 47 | 0.160 |
Why?
| | Lipoproteins, LDL | 1 | 2019 | 128 | 0.160 |
Why?
| | Humans | 13 | 2022 | 114757 | 0.160 |
Why?
| | Semaphorins | 1 | 2018 | 21 | 0.150 |
Why?
| | Actins | 1 | 2020 | 381 | 0.150 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2021 | 342 | 0.150 |
Why?
| | Mammary Glands, Human | 1 | 2018 | 60 | 0.150 |
Why?
| | Mice, 129 Strain | 1 | 2017 | 75 | 0.150 |
Why?
| | Chikungunya virus | 1 | 2018 | 61 | 0.140 |
Why?
| | Sulfonamides | 1 | 2020 | 445 | 0.140 |
Why?
| | Cell Communication | 1 | 2019 | 279 | 0.140 |
Why?
| | Hypersensitivity | 1 | 2020 | 254 | 0.140 |
Why?
| | Adaptive Immunity | 1 | 2018 | 156 | 0.140 |
Why?
| | Amino Acids | 1 | 2020 | 448 | 0.140 |
Why?
| | Peptide Fragments | 1 | 2021 | 668 | 0.140 |
Why?
| | Cell Division | 1 | 2019 | 759 | 0.140 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2020 | 965 | 0.140 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2021 | 642 | 0.140 |
Why?
| | Base Sequence | 1 | 2020 | 2118 | 0.140 |
Why?
| | Head and Neck Neoplasms | 1 | 2021 | 436 | 0.140 |
Why?
| | Phosphorylation | 1 | 2020 | 1571 | 0.130 |
Why?
| | Down Syndrome | 1 | 2020 | 338 | 0.130 |
Why?
| | Transcriptome | 1 | 2021 | 727 | 0.130 |
Why?
| | CD27 Ligand | 1 | 2015 | 9 | 0.130 |
Why?
| | Female | 8 | 2020 | 59507 | 0.130 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1 | 2015 | 27 | 0.130 |
Why?
| | Cell Survival | 1 | 2018 | 1021 | 0.120 |
Why?
| | Dose-Response Relationship, Immunologic | 1 | 2014 | 76 | 0.120 |
Why?
| | RNA, Messenger | 1 | 2021 | 2557 | 0.110 |
Why?
| | Chronic Disease | 1 | 2019 | 1590 | 0.110 |
Why?
| | DNA Damage | 2 | 2005 | 357 | 0.110 |
Why?
| | Epithelial Cells | 1 | 2018 | 955 | 0.100 |
Why?
| | Immunologic Memory | 1 | 2013 | 313 | 0.100 |
Why?
| | Th17 Cells | 1 | 2012 | 58 | 0.100 |
Why?
| | Interleukin-12 | 1 | 2012 | 110 | 0.090 |
Why?
| | CD40 Antigens | 1 | 2012 | 82 | 0.090 |
Why?
| | Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2010 | 11 | 0.090 |
Why?
| | Lipoproteins | 1 | 2012 | 160 | 0.090 |
Why?
| | Cysteine | 1 | 2012 | 171 | 0.090 |
Why?
| | Time Factors | 1 | 2021 | 6124 | 0.090 |
Why?
| | Male | 5 | 2020 | 55579 | 0.090 |
Why?
| | Antineoplastic Agents | 1 | 2020 | 1895 | 0.090 |
Why?
| | Apoptosis | 1 | 2019 | 2369 | 0.090 |
Why?
| | ras Proteins | 1 | 2010 | 138 | 0.090 |
Why?
| | Transcription, Genetic | 2 | 2006 | 1316 | 0.080 |
Why?
| | Inheritance Patterns | 1 | 2009 | 45 | 0.080 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2009 | 66 | 0.080 |
Why?
| | Histone Acetyltransferases | 2 | 2008 | 51 | 0.080 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 743 | 0.080 |
Why?
| | DNA, Fungal | 1 | 2008 | 69 | 0.080 |
Why?
| | Aged, 80 and over | 1 | 2019 | 6350 | 0.080 |
Why?
| | Combined Modality Therapy | 2 | 2021 | 1122 | 0.070 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2008 | 88 | 0.070 |
Why?
| | Gene Regulatory Networks | 1 | 2009 | 228 | 0.070 |
Why?
| | Lysine | 2 | 2008 | 242 | 0.070 |
Why?
| | Neoplasms | 1 | 2020 | 2105 | 0.070 |
Why?
| | Genes, Fungal | 1 | 2006 | 49 | 0.070 |
Why?
| | Genes, Dominant | 1 | 2006 | 94 | 0.070 |
Why?
| | Acid Phosphatase | 1 | 2005 | 17 | 0.060 |
Why?
| | Checkpoint Kinase 2 | 1 | 2005 | 21 | 0.060 |
Why?
| | Genetic Complementation Test | 1 | 2005 | 62 | 0.060 |
Why?
| | Deoxyribonucleases, Type II Site-Specific | 1 | 2005 | 17 | 0.060 |
Why?
| | Sirtuin 2 | 1 | 2005 | 12 | 0.060 |
Why?
| | Acetyltransferases | 1 | 2005 | 20 | 0.060 |
Why?
| | Immunoprecipitation | 1 | 2005 | 152 | 0.060 |
Why?
| | Sirtuins | 1 | 2005 | 32 | 0.060 |
Why?
| | Conserved Sequence | 1 | 2005 | 218 | 0.060 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2005 | 353 | 0.060 |
Why?
| | Acetylation | 1 | 2005 | 211 | 0.060 |
Why?
| | DNA Replication | 1 | 2005 | 205 | 0.060 |
Why?
| | Bleomycin | 1 | 2005 | 228 | 0.060 |
Why?
| | Drosophila Proteins | 1 | 2005 | 163 | 0.060 |
Why?
| | Green Fluorescent Proteins | 1 | 2005 | 373 | 0.060 |
Why?
| | Drosophila melanogaster | 1 | 2005 | 191 | 0.060 |
Why?
| | Vaccination | 1 | 2012 | 1205 | 0.060 |
Why?
| | Histone Deacetylases | 1 | 2005 | 195 | 0.060 |
Why?
| | Protein Kinases | 1 | 2005 | 307 | 0.050 |
Why?
| | Binding Sites | 1 | 2006 | 1176 | 0.050 |
Why?
| | Alphavirus | 1 | 2021 | 17 | 0.050 |
Why?
| | Kupffer Cells | 1 | 2021 | 45 | 0.050 |
Why?
| | Amino Acid Sequence | 1 | 2005 | 1988 | 0.050 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2021 | 18 | 0.050 |
Why?
| | Mice, Mutant Strains | 1 | 2021 | 271 | 0.050 |
Why?
| | Aged | 1 | 2019 | 19094 | 0.050 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2021 | 66 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 1 | 2009 | 2099 | 0.050 |
Why?
| | Lymphocyte Depletion | 1 | 2021 | 116 | 0.050 |
Why?
| | Molecular Sequence Data | 1 | 2005 | 2791 | 0.050 |
Why?
| | Protein Binding | 1 | 2006 | 1897 | 0.040 |
Why?
| | Tumor Burden | 1 | 2021 | 261 | 0.040 |
Why?
| | Melanoma, Experimental | 1 | 2020 | 89 | 0.040 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 166 | 0.040 |
Why?
| | Purines | 1 | 2020 | 159 | 0.040 |
Why?
| | Interferon-alpha | 1 | 2020 | 187 | 0.040 |
Why?
| | Middle Aged | 1 | 2019 | 26757 | 0.040 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 295 | 0.040 |
Why?
| | Lymphangiogenesis | 1 | 2018 | 24 | 0.040 |
Why?
| | Venules | 1 | 2018 | 13 | 0.040 |
Why?
| | GPI-Linked Proteins | 1 | 2018 | 54 | 0.040 |
Why?
| | Crosses, Genetic | 1 | 2018 | 140 | 0.040 |
Why?
| | DNA-Binding Proteins | 1 | 2005 | 1314 | 0.040 |
Why?
| | RNA, Viral | 1 | 2021 | 566 | 0.040 |
Why?
| | Stromal Cells | 1 | 2018 | 96 | 0.040 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2020 | 196 | 0.040 |
Why?
| | Integrins | 1 | 2018 | 79 | 0.040 |
Why?
| | Adult | 1 | 2019 | 30548 | 0.040 |
Why?
| | Mammary Glands, Animal | 1 | 2018 | 116 | 0.040 |
Why?
| | Pyrazoles | 1 | 2020 | 364 | 0.040 |
Why?
| | Transcription Factors | 1 | 2005 | 1528 | 0.040 |
Why?
| | Neoplasm Metastasis | 1 | 2018 | 528 | 0.030 |
Why?
| | Epitopes | 1 | 2018 | 435 | 0.030 |
Why?
| | Immunization | 1 | 2018 | 401 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2020 | 723 | 0.030 |
Why?
| | Coculture Techniques | 1 | 2015 | 201 | 0.030 |
Why?
| | Phenotype | 1 | 2021 | 2812 | 0.030 |
Why?
| | B-Lymphocytes | 1 | 2018 | 769 | 0.030 |
Why?
| | Vaccines, Subunit | 1 | 2012 | 42 | 0.030 |
Why?
| | Immunity, Humoral | 1 | 2012 | 112 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2018 | 3542 | 0.020 |
Why?
| | DNA Breaks, Double-Stranded | 1 | 2008 | 30 | 0.020 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2008 | 129 | 0.020 |
Why?
| | Phosphoproteins | 1 | 2008 | 299 | 0.020 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2008 | 368 | 0.020 |
Why?
| | Models, Biological | 1 | 2008 | 1630 | 0.010 |
Why?
|
|
Tamburini's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|